Meta tags:
description= Home to the journal Oncology, Cancer Network provides research and opinion on the screening, early detection, diagnosis, treatment, and prevention of cancers.;
Headings (most frequently used words):
news, latest, all, oncology,
Text of the page (most frequently used words):
cancer (59), 2024 (32), #april (30), the (28), #with (25), #cancers (22), for (22), #breast (22), and (18), #patients (17), oncology (16), #gastrointestinal (13), cme (12), #more (9), #hematologic (9), surgery (9), pelosci (9), leukemia (9), ariana (9), treatment (8), view (8), gynecologic (8), genitourinary (8), from (7), cne (7), lymphoma (7), outcomes (7), russ (7), conroy (7), lung (7), those (6), thyroid (6), #news (6), acute (6), benefit (6), refractory (5), relapsed (5), myeloma (5), cell (5), advanced (5), trial (5), infection (5), practice (5), latest (5), data (5), melanoma (5), care (5), all (5), 12th (5), her2 (5), com (4), 10th (4), patient (4), 17th (4), combo (4), aml (4), 16th (4), 15th (4), myeloid (4), fda (4), response (4), may (4), phase (4), delays (4), related (4), 11th (4), mauro (4), tumors (4), gina (4), pediatric (4), yields (4), multiple (4), clinical (4), screening (3), chemotherapy (3), risk (3), burst (3), events (3), fast (3), observed (3), track (3), designation (3), end (3), point (3), real (3), world (3), head (3), accredited (3), findings (3), non (3), neck (3), media (3), archived (3), shows (3), webcast (3), plus (3), improved (3), were (3), recurrent (3), support (3), covid (3), annual (3), not (3), biomarkers (3), lyt (2), trials (2), connections (2), can (2), microwave (2), treated (2), option (2), barriers (2), olutasidenib (2), idh1 (2), 200 (2), mutated (2), ablation (2), caregiver (2), community (2), 14th (2), therapy (2), relapse (2), late (2), experts (2), updates (2), iyengar (2), presented (2), meeting (2), management (2), neil (2), conference (2), miami (2), 41st (2), across (2), sacituzumab (2), tirumotecan (2), trop2 (2), glofitamab (2), hodgkin (2), after (2), have (2), found (2), savolitinib (2), osimertinib (2), elicited (2), egfr (2), met (2), nsclc (2), 13th (2), connection (2), centers (2), provider (2), durvalumab (2), nurse (2), melissa (2), breaking (2), glp1 (2), use (2), tract (2), novel (2), biliary (2), early (2), time (2), analysis (2), starglo (2), now (2), brain (2), hormone (2), immunotherapy (2), elderly (2), show (2), mesothelioma (2), neuroendocrine (2), toripalimab (2), radiation (2), sarcoma (2), effects (2), skin (2), spotlight (2), high (2), conferences (2), publications (2), metastatic (2), resources (2), subscribe (2), adverse (2), choose (2), rintatolimod (2), between (2), contact (2), advertisement (2), see (2), sponsored (2), hospitals (2), around (2), rectal (2), lines (2), concepts (2), specialty (2), contemporary (2), assess (2), linvoseltamab (2), oncview (2), podcasts (2), readout (2), responses (2), tamibarotene (2), approval (2), 360 (2), likely (2), younger (2), less (2), ovarian (2), diagnostic (2), are (2), aditya, haiyan, yodkhunnatham, nuphat, bagrodia, disparities, month, zhang, nonseminomatous, right, original, satellite, sessions, contralateral, discusses, germ, vavinskaya, vera, assistants, significant, showed, partners, topaz, practitioners, testicular, physician, evaluation, jared, forrester, langner, interactive, joanna, millard, tools, awareness, frederick, quandary, langer, meets, dlbcl, face, off, minute, drill, alert, global, medical, presentations, upcoming, will, bulletin, large, diffuse, topics, several, rounds, frontline, keller, wolf, forum, authors, editorial, board, journals, algorithms, brothers, morning, laura, according, space, evolving, new, training, focused, academy, alone, who, myelodysplastic, settings, approaches, glioma, applying, current, considerations, opportunities, earns, pandemic, syndromes, nursing, plan, your, agent, imaging, pet, light, shining, focus, kahl, parp, optimize, effectively, crc, kristie, how, exacerbated, inequities, first, next, regimens, what, plans, equalizing, has, cholangiocarcinoma, lymphocytic, ronald, tnbc, down, journal, results, agonist, receptor, increased, agents, indications, small, against, advised, should, medullary, predisposed, targeted, identifying, presence, til, activities, optimizing, insights, neoadjuvant, during, concerns, addressing, mayo, clinic, case, translating, videos, evidence, survival, hilary, improve, discussion, based, fluke, bremer, additional, confer, women, symptoms, their, concern, due, partly, system, reason, young, effect, synergistic, pembrolizumab, national, combining, rcc, chinese, receives, carcinoma, renal, unresectable, medium, china, regimen, approved, mostly, accreditation, population, biopsy, valuable, potentially, noninferiority, papillary, t1n0m0, multifocal, instead, omission, slnb, sound, arm, node, program, lymph, sentinel, comparable, appear, oncologic, underestimated, process, throughout, occurred, where, intervals, looked, axitinib, posttransplant, remissions, sell, advertise, curetoday, onclive, oncnursingnews, targetedonc, conditions, terms, privacy, information, personal, info, hospital, 08512, cranbury, drive, commerce, 7777, 716, 609, reserved, rights, sciences, life, about, mortality, studies, safety, future, benchmark, serve, diagnosed, newly, grants, overexpression, gene, rara, harboring, potential, select, rosa, complication, kristi, mm3, linker, part, look, also, investigators, surgical, 9th, undergoing, lower, rates, enduring, previously, gej, catherine, staging, performing, utility, rice, ashlee, winter, kendra, sizer, lina, carruthers, shin, over, eunice, carter, bradford, car, doherty, kyle, efficacious, was, hr001, conserving, mri, age, radiotherapy, talk, gastric, efficacy, expression, setting, beyond, line, third, second, prominently, advances, institutional, key, surgeons, shannon, bruce, adrienne, dineen, sean, waheed, talha, muhammad, sso, inequalities, well, discuss, recurrence, predict, currently, approves, wadsten, lotta, resistant, flaherty, courtney, amplified, proteogenomic, holds, association, severe, lymphoblastic, mrd, odac, shivers, approvals, accelerated, leading, considered, disease, residual, minimal, gives, malignancies, solid, investigated, being, steven, charles, invasive, naamit, stage, biosignature, mjh, troy, mittal, karuna, shah, chirag, vicini, frank, gerber, whittemore, krystel, yates, clayton, karanam, balusubramanyam, acs, geza, pernicone, elizabeth, tempest, facs, cox, network,
Text of the page (random words):
cancer network news clinical topics global bulletin all news approval alert media 2 minute drill around the practice between the lines breaking barriers face off morning rounds oncview podcasts readout 360 sponsored media training academy treatment algorithms with the oncology brothers conferences publications all journals editorial board for authors events frontline forum satellite sessions cme ce resources contemporary concepts awareness month interactive tools nurse practitioners physician s assistants partners sponsored subscribe choose specialty adverse effects biomarkers brain cancer breast cancer breast cancer breast cancer gastrointestinal cancer gastrointestinal cancer gastrointestinal cancer gastrointestinal cancer gastrointestinal cancer gastrointestinal cancer genitourinary cancers genitourinary cancers genitourinary cancers genitourinary cancers gynecologic cancers gynecologic cancers gynecologic cancers gynecologic cancers head neck cancer hematologic oncology hematologic oncology hematologic oncology hematologic oncology hormone related cancers immunotherapy infection infection leukemia lung cancer lung cancer lung cancer lymphoma melanoma mesothelioma neuroendocrine tumors oncology pediatric cancers radiation oncology sarcoma screening skin cancer melanoma surgery thyroid cancer spotlight around the practice between the lines contemporary concepts journal oncview podcasts readout 360 insights from experts at mayo clinic on translating evidence to clinical practice optimizing outcomes in patients with her2 metastatic breast cancer choose specialty adverse effects biomarkers brain cancer breast cancer breast cancer breast cancer gastrointestinal cancer gastrointestinal cancer gastrointestinal cancer gastrointestinal cancer gastrointestinal cancer gastrointestinal cancer genitourinary cancers genitourinary cancers genitourinary cancers genitourinary cancers gynecologic cancers gynecologic cancers gynecologic cancers gynecologic cancers head neck cancer hematologic oncology hematologic oncology hematologic oncology hematologic oncology hormone related cancers immunotherapy infection infection leukemia lung cancer lung cancer lung cancer lymphoma melanoma mesothelioma neuroendocrine tumors oncology pediatric cancers radiation oncology sarcoma screening skin cancer melanoma surgery thyroid cancer spotlight news media conferences publications events cme ce resources subscribe advertisement latest news younger patients with her2 breast cancer may benefit from surgery first by kristie l kahl april 17th 2024 covid 19 pandemic has exacerbated crc surgery disparities by russ conroy april 17th 2024 pet imaging agent earns fda fast track designation in recurrent glioma by russ conroy april 17th 2024 identifying indications for neoadjuvant therapy in cholangiocarcinoma by hilary r keller md laura fluke do jared a forrester md ronald f wolf md april 17th 2024 survival outcomes improve with til presence in tnbc by ariana pelosci april 16th 2024 latest videos latest cme events activities burst cme cme cne the latest on acute lymphocytic leukemia view more burst cme cme cne a focus on acute myeloid leukemia view more burst cme cme cne updates in myelodysplastic syndromes view more archived webcast cme equalizing inequities in multiple myeloma care shining a light on current barriers and opportunities for improved outcomes view more community practice connections cme cne community practice connections what s next for patients with breast cancer and how can we effectively optimize parp her2 3 and trop2 targeted regimens in treatment plans view more archived webcast cne show me your care plan nursing considerations for applying the latest approaches across care settings in melanoma view more patient provider caregiver connection cme cne patient provider and caregiver connection addressing patient concerns during the treatment and management of hr her2 breast cancer view more archived webcast cne breaking down biomarkers in non small cell lung cancer a case based discussion for the oncology nurse view more all oncology news increased thyroid cancer risk not observed after use of glp1 receptor agonist by ariana pelosci april 16th 2024 patients who are predisposed to medullary thyroid cancer should be advised against the use of glp1 agents durvalumab combo yields os benefit in advanced biliary tract cancer by ariana pelosci april 16th 2024 the phase 3 topaz 1 trial of durvalumab plus chemotherapy showed a significant benefit vs chemotherapy alone for patients with advanced biliary tract cancer evaluation and management of testicular cancer after late relapse by joanna l langner ms frederick millard md vera vavinskaya md haiyan zhang md nuphat yodkhunnatham md aditya bagrodia md april 16th 2024 the clinical quandary by langer et al discusses a contralateral late relapse of the original right nonseminomatous germ cell tumors updates in breast cancer care from the 41st annual miami breast cancer conference by neil m iyengar md april 15th 2024 several presentations from the 41st annual miami breast cancer conference focused on new and evolving data in the space according to neil m iyengar md starglo trial meets os end point with glofitamab in relapsed refractory dlbcl by ariana pelosci april 15th 2024 additional data and results from the phase 3 starglo trial of glofitamab for patients with relapsed refractory diffuse large b cell lymphoma will be presented at an upcoming medical meeting sacituzumab tirumotecan shows early efficacy in gastric gej cancers by gina mauro april 15th 2024 sacituzumab tirumotecan elicited responses prominently in the second and third line and beyond setting and in those with high trop2 expression surgeons talk key treatment and institutional advances across oncology care by adrienne bruce shannon md sean dineen md muhammad talha waheed md april 15th 2024 experts discuss findings related to gastrointestinal cancer outcomes as well as treatment inequalities presented at the 2024 sso annual meeting 71 utility of performing staging mri in breast cancer patients over the age of 75 by ashlee rice kendra winter lina sizer catherine carruthers eunice shin w bradford carter april 14th 2024 novel car t cell therapy yields response in r r non hodgkin lymphoma by kyle doherty april 14th 2024 hr001 was found to have an efficacious response for patients with relapsed refractory non hodgkin lymphoma 72 a novel biosignature for early stage invasive breast cancer to predict radiotherapy benefit and assess recurrence risk for patients treated with breast conserving surgery by troy bremer karuna mittal chirag shah md frank vicini md naamit gerber melissa krystel whittemore clayton c yates balusubramanyam karanam geza acs elizabeth pernicone melissa tempest charles e cox ms facs steven c shivers lotta wadsten april 13th 2024 response observed with savolitinib combo in egfr met osimertinib resistant nsclc by courtney flaherty april 13th 2024 a proteogenomic analysis found savolitinib plus osimertinib elicited a response in patients with egfr mutated met amplified advanced nsclc covid 19 and chemotherapy association holds in pediatric leukemia lymphoma by ariana pelosci april 12th 2024 pediatric patients with acute lymphoblastic leukemia lymphoma were less likely to have severe covid 19 infection odac approves mrd end point in multiple myeloma trials by ariana pelosci april 12th 2024 minimal residual disease can now be considered an end point in trials leading to accelerated approvals by the fda for multiple myeloma fda gives fast track designation to lyt 200 in advanced head and neck cancers by ariana pelosci april 12th 2024 lyt 200 is currently being investigated for those with solid tumors and hematologic malignancies olutasidenib yields enduring remissions in previously treated idh1 aml by russ conroy april 12th 2024 phase 2 findings support olutasidenib as a potentially valuable treatment option in idh1 mutated acute myeloid leukemia microwave ablation shows noninferiority to surgery in thyroid cancer by gina mauro april 12th 2024 microwave ablation may be a go to treatment option instead of surgery for patients with multifocal t1n0m0 papillary thyroid cancer real world data support slnb omission in hr her2 breast cancer by russ conroy april 11th 2024 oncologic outcomes from a real world analysis appear to be comparable with those observed in the sentinel lymph node biopsy arm of the sound trial time to screening treatment surgery is underestimated at breast centers by ariana pelosci april 11th 2024 the national accreditation program for breast centers looked at time intervals to see where delays occurred throughout the process for those with breast cancer diagnostic delays in younger women with breast cancer are mostly patient related by gina mauro april 11th 2024 young patients with breast cancer were more likely to be the reason for diagnostic delays vs system delays partly due to less concern for their symptoms rintatolimod combo yields clinical benefit in recurrent ovarian cancer by russ conroy april 11th 2024 combining rintatolimod with pembrolizumab may confer a synergistic effect in patients with recurrent ovarian cancer toripalimab combo receives chinese approval for advanced rcc by ariana pelosci april 10th 2024 toripalimab plus axitinib is now an approved regimen in china for patients with medium to high risk unresectable or metastatic renal cell carcinoma data show improved posttransplant outcomes in elderly aml population by russ conroy april 10th 2024 real world data may serve as a benchmark for future studies in elderly patients with acute myeloid leukemia fda grants fast track designation to tamibarotene in newly diagnosed aml by russ conroy april 10th 2024 findings from select aml 1 support the potential benefit of tamibarotene in those with acute myeloid leukemia harboring rara gene overexpression linvoseltamab shows responses safety in relapsed refractory myeloma by kristi rosa april 10th 2024 investigators also look to assess linvoseltamab in relapsed refractory multiple myeloma as part of the phase 3 linker mm3 trial rectal cancer surgical outcomes improved at accredited hospitals by gina mauro april 9th 2024 in hospital mortality and complication rates were lower at accredited hospitals vs those not accredited for patients undergoing rectal cancer surgery see all news advertisement about advertise curetoday com onclive com oncnursingnews com targetedonc com contact terms and conditions privacy do not sell my personal information contact info 2 commerce drive cranbury nj 08512 609 716 7777 2024 mjh life sciences all rights reserved
|